Reversal of resistance by N-acetyltyramine or N-acetyl-2-phenylethylamine in doxorubicin-resistant leukemia P388 cells.
S
S
Kunimoto
C Z
CZ
Xu
H
H
Naganawa
M
M
Hamada
T
T
Masuda
T
T
Takeuchi
H
H
Umezawa
D000818:Animals; D002478:Cells, Cultured; D004317:Doxorubicin / Q000494:pharmacology* / Q000627:therapeutic use; D007275:Injections, Intravenous; D007941:Leukemia P388 / Q000188:drug therapy / Q000378:metabolism; D051379:Mice; D008815:Mice, Inbred Strains; D008826:Microbial Sensitivity Tests; D010627:Phenethylamines / Q000302:isolation & purification / Q000494:pharmacology* / Q000627:therapeutic use; D013302:Streptomyces / Q000187:drug effects*; D014439:Tyramine / Q000031:analogs & derivatives* / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use
D010627:Phenethylamines; D004317:Doxorubicin; C054480:N-acetyl-2-phenylethylamine; C054479:N-acetyltyramine; D014439:Tyramine